CH EMED EPR
2.0.1-ci-build - ci-build Switzerland flag

CH EMED EPR, published by CARA. This guide is not an authorized publication; it is the continuous build for version 2.0.1-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/CARA-ch/ch-emed-epr/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Changelog
... 3 Document Dis
... 4 Document Mtp
... 5 Document Padv
... 6 Document Pml
... 7 Document Pmlc
... 8 Document Pre
... 9 Guidance Amount Quantity
... 10 Guidance Comments
... 11 Guidance Compositions
... 12 Guidance Datatypes
... 13 Guidance Index
... 14 Guidance Others
... 15 Guidance Treatment
... 16 Use Case
... 17 Workflow
... 18 Artifacts Summary
.... 18.1 Body Weight Observation
.... 18.2 CH EMED EPR Device
.... 18.3 CH EMED EPR Medication
.... 18.4 CH EMED EPR Medication (DIS)
.... 18.5 CH EMED EPR Organization
.... 18.6 CH EMED EPR Patient
.... 18.7 CH EMED EPR Practitioner
.... 18.8 CH EMED EPR PractitionerRole
.... 18.9 CH EMED EPR RelatedPerson
.... 18.10 DIS Composition
.... 18.11 DIS Document
.... 18.12 DIS MedicationDispense
.... 18.13 MTP Composition
.... 18.14 MTP Document
.... 18.15 MTP MedicationStatement
.... 18.16 PADV Changed MedicationRequest
.... 18.17 PADV Changed MedicationStatement
.... 18.18 PADV Composition
.... 18.19 PADV Document
.... 18.20 PADV Observation
.... 18.21 PML Changed Medication Request
.... 18.22 PML Changed MedicationStatement
.... 18.23 PML Composition
.... 18.24 PML Document
.... 18.25 PML MedicationDispense
.... 18.26 PML MedicationRequest
.... 18.27 PML MedicationStatement
.... 18.28 PML Observation
.... 18.29 PMLC Composition
.... 18.30 PMLC Document
.... 18.31 PMLC MedicationStatement
.... 18.32 PRE Composition
.... 18.33 PRE Document
.... 18.34 PRE MedicationRequest
.... 18.35 Amount Quantity
.... 18.36 Amount Range
.... 18.37 Dosage (MedicationRequest)
.... 18.38 Dosage (MedicationStatement / MedicationDispense)
.... 18.39 Dosage Split
.... 18.40 Ratio (Amount / Amount)
.... 18.41 Ratio (Amount / Time)
.... 18.42 Time Quantity
.... 18.43 Amount Quantity Unit Codes
.... 18.44 Event Timings
.... 18.45 Paper Formats
.... 18.46 Route of Administration
.... 18.47 Substance Administration Substitution Codes
.... 18.48 Time Quantity Unit Codes
.... 18.49 CH EMED EPR Paper Format Code System
.... 18.50 CdTyp26 -> RouteOfAdministrationEDQM
.... 18.51 CdTyp9 -> CHEMEDEPRAmountQuantityUnitCode
.... 18.52 CdTyp9 -> CHEMEDEPRTimeQuantityUnitCode
.... 18.53 CHEMEDEPRAmountQuantityUnitCode -> CdTyp9
.... 18.54 CHEMEDEPRTimeQuantityUnitCode -> CdTyp9
.... 18.55 RouteOfAdministrationEDQM -> CdTyp26
.... 18.56 Bundle: DIS 1
.... 18.57 Bundle: MTP 1
.... 18.58 Bundle: MTP Dafalgan Effervescent CARAPMP004
.... 18.59 Bundle: MTP Paracetamol CARAPMP004
.... 18.60 Bundle: PADV 1
.... 18.61 Bundle: PADV 2
.... 18.62 Bundle: PADV CANCEL paracetamol Axapharm
.... 18.63 Bundle: PADV CHANGE paracetamol Axapharm
.... 18.64 Bundle: PML #1
.... 18.65 Bundle: PMLC document with a prescribed axapharm paracetamol treatment
.... 18.66 Bundle: PMLC document with a prescribed dafalgan effervescent paracetamol treatment
.... 18.67 Bundle: PMLC #1
.... 18.68 Bundle: PRE 1
.... 18.69 Bundle: PRE Dafalgan eff 500mg
.... 18.70 Bundle: PRE Paracetamol Axapharm 1g
.... 18.71 Bundle: use case PML #1
.... 18.72 Bundle: use case PML #6b
.... 18.73 Changed Medication Statement: Triatec (PADV)
.... 18.74 Composition for PMLC document with a prescribed dafalgan effervescent paracetamol treatment
.... 18.75 Composition: PMLC document with a prescribed axapharm paracetamol treatment
.... 18.76 Composition: use case PML #1
.... 18.77 Composition: use case PML #6b
.... 18.78 Device: PMP Aggregator
.... 18.79 Medication: Triatec
.... 18.80 MedicationDispense: Triatec (DIS)
.... 18.81 MedicationDispense: Triatec (PML)
.... 18.82 MedicationNorvasc
.... 18.83 MedicationParacetamolAxapharm
.... 18.84 MedicationParacetamolDafalganEff
.... 18.85 MedicationRamipril
.... 18.86 MedicationRequest: Dafalgan effervescent 500mg (PRE)
.... 18.87 MedicationRequest: Paracetamol Axapharm 1g (PML)
.... 18.88 MedicationRequest: Paracetamol Axapharm 1g (PRE)
.... 18.89 MedicationRequest: Triatec (PML)
.... 18.90 MedicationRequest: Triatec (PRE)
.... 18.91 MedicationStatement: Paracetamol Axapharm (MTP)
.... 18.92 MedicationStatement: Paracetamol Axapharm (PML)
.... 18.93 MedicationStatement: Paracetamol Axapharm (PMLC)
.... 18.94 MedicationStatement: Paracetamol Dafalgan Effervescent (MTP)
.... 18.95 MedicationStatement: Paracetamol Dafalgan Effervescent (MTP) with max dose per period
.... 18.96 MedicationStatement: Paracetamol Dafalgan Effervescent (MTP) with split dose
.... 18.97 MedicationStatement: Paracetamol Dafalgan Effervescent (PMLC)
.... 18.98 MedicationStatement: Triatec (MTP)
.... 18.99 MedicationWithATC
.... 18.100 MedicationWithTwoIngredients
.... 18.101 Observation: CANCEL of Axapharm paracetamol treatment.
.... 18.102 Observation: CHANGE of Axapharm paracetamol prescription, replaced with Dafalgan eff.
.... 18.103 Observation: CHANGE of Axapharm paracetamol prescription, replaced with Dafalgan eff.
.... 18.104 Observation: Ramipril (PADV)
.... 18.105 Observation: Triatec (PADV)
.... 18.106 Observation: Triatec (PML)
.... 18.107 Organization: CARA
.... 18.108 Organization: HUG
.... 18.109 Patient: Dupont
.... 18.110 Patient: Michaël Christopher KARCE
.... 18.111 Practitioner: Perry Cox
.... 18.112 PractitionerRole: Perry Cox @ HUG